BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34078311)

  • 41. The treatment sequence may matter in patients undergoing pancreatoduodenectomy for early stage pancreatic cancer in the era of modern chemotherapy.
    Watson MD; Thompson KJ; Musselwhite LW; Hwang JJ; Baker EH; Martinie JB; Vrochides D; Iannitti DA; Ocuin LM
    Am J Surg; 2021 Jul; 222(1):159-166. PubMed ID: 33121658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
    Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of breast cancer treatment at a tertiary-level institution with Popular Health Insurance in Mexico].
    Arce-Salinas C; Lara-Medina FU; Alvarado-Miranda A; Castañeda-Soto N; Bargalló-Rocha E; Ramírez-Ugalde MT; Pérez-Sánchez V; Rivera L; Gambo-Vignole C; Santamaría-Galicia J; Nieves-Casas RI; Morán-Muñoz H; Mohar-Betancourt A
    Rev Invest Clin; 2012; 64(1):9-16. PubMed ID: 22690524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequential therapy of advanced buccal mucosa squamous cell carcinoma: three-year outcome.
    Lyu J; Li C; Wu Y; Wang R; Ren G; Guo W
    J Oral Maxillofac Surg; 2014 Mar; 72(3):606-10. PubMed ID: 24342583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
    Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
    Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low body mass index at 3 months following adjuvant chemoradiation affects survival of postoperative locally advanced oral cavity cancer patients.
    Chang PH; Wang CH; Huang JS; Lai CH; Wu TH; Lan YJ; Tsai JC; Chen EY; Yang SW; Yeh KY
    Laryngoscope; 2012 Oct; 122(10):2193-8. PubMed ID: 22886710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients.
    Freier K; Engel M; Lindel K; Flechtenmacher C; Mühling J; Hassfeld S; Hofele C
    Oral Oncol; 2008 Feb; 44(2):116-23. PubMed ID: 17350327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Where we Stand; An Italian Single Center Perspective.
    Marino E; Graziosi L; Donini A
    In Vivo; 2021; 35(6):3459-3466. PubMed ID: 34697182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.
    Savic M; Kontic M; Ercegovac M; Stojsic J; Bascarevic S; Moskovljevic D; Kostic M; Vesovic R; Popevic S; Laban M; Markovic J; Jovanovic D
    Thorac Cancer; 2017 Sep; 8(5):393-401. PubMed ID: 28671758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer.
    Huang CM; Huang MY; Ma CJ; Yeh Y-; Tsai HL; Huang CW; Huang CJ; Wang JY
    Radiat Oncol; 2017 Mar; 12(1):48. PubMed ID: 28270172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neoadjuvant Chemotherapy Creates Surgery Opportunities For Inoperable Locally Advanced Breast Cancer.
    Wang M; Hou L; Chen M; Zhou Y; Liang Y; Wang S; Jiang J; Zhang Y
    Sci Rep; 2017 Mar; 7():44673. PubMed ID: 28327615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 54. [Efficacy of neoadjuvant chemotherpy in patients with locally advanced gastric cancer].
    Wang Y; Liu TS; Zhuang RY; Cui YH; Wang ZM; Yu YY; Hou J; Sun YH; Shen KT; Shen ZB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):166-9. PubMed ID: 23446480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma.
    Ruf C; Thomusch O; Goos M; Makowiec F; Illerhaus G; Ruf G
    BMC Surg; 2014 Jan; 14():5. PubMed ID: 24461063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
    Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
    Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contemporary Treatment of Locally Advanced Oral Cancer.
    Kim D; Li R
    Curr Treat Options Oncol; 2019 Mar; 20(4):32. PubMed ID: 30874958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
    Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
    Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy.
    Hajiran A; Azizi M; Aydin AM; Zemp L; Peyton CC; Dhillon J; Nealon S; Reich RR; Cao B; Li R; Manley BJ; Sexton WJ; Gilbert SM
    J Urol; 2021 Jan; 205(1):100-108. PubMed ID: 32783489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases.
    Li R; Wang Q; Zhang B; Yuan Y; Xie W; Huang X; Zhou C; Zhang S; Niu S; Chang H; Chen D; Miao H; Zeng ZF; Xiao W; Gao Y
    BMC Cancer; 2021 Dec; 21(1):1333. PubMed ID: 34906114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.